Localization and Concentration of Carcinoembryonic Antigen (CEA) in Gastrointestinal Tumors: Correlation with CEA Levels in Plasma
Overview
Affiliations
In 50 patients with gastrointestinal carcinomas, the following tumor parameters were studied: the concentration and localization of carcinoembryonic antigen (CEA) in tissue, extension, invasion, infiltration, differentiation, and necrosis. CEA concentrations were measured in plasma samples of all patients. In 7 patients with gastric carcinomas, CEA concentrations in tissue were low. Generally, only single cells or cell groups were CEA-positive. Elevated CEA levels in plasma resulted mainly from distant metastases and not from the primary tumor. In 43 colorectal carcinomas, CEA concentrations in tissue varied between 1.5 and 472 microgram/g tissue. They were closely related to the degree of accumulation of CEA-positive necrotic material in the degree of accumulation of CEA-positive necrotic material in the neoplastic glands. In 35 patients with colorectal carcinomas without CEA producing distant metastases, preoperative CEA levels in plasma were normal when tumor necrosis and perineural invasion were absent and CEA concentrations in tissue were low. CEA levels in plasma were regularly elevated when the tumor showed considerable necrosis in the presence of high CEA concentrations in tissue.
Boogerd L, Vuijk F, Hoogstins C, Handgraaf H, van der Valk M, Kuppen P Biomark Cancer. 2017; 9:1179299X17710016.
PMID: 28579847 PMC: 5437985. DOI: 10.1177/1179299X17710016.
Lee S, Min K, Chung J, Jung I, Ahn Y, Hwang K J Korean Surg Soc. 2011; 81(6):387-93.
PMID: 22200039 PMC: 3243855. DOI: 10.4174/jkss.2011.81.6.387.
Regulation of carcinoembryonic antigen release from colorectal cancer cells.
Pakdel A, Naghibalhossaini F, Mokarram P, Jaberipour M, Hosseini A Mol Biol Rep. 2011; 39(4):3695-704.
PMID: 21725636 DOI: 10.1007/s11033-011-1144-0.
Li M, Li J, Zhao A, He J, Zhou L, Li Y Colorectal Dis. 2008; 11(3):276-81.
PMID: 18513194 PMC: 3002045. DOI: 10.1111/j.1463-1318.2008.01591.x.
Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients.
Wilmanns C, Grossmann J, Steinhauer S, Manthey G, Weinhold B, Schmitt-Graff A Clin Exp Metastasis. 2004; 21(1):75-8.
PMID: 15065605 DOI: 10.1023/b:clin.0000017204.38807.22.